Spontaneous Acetabular Periprosthetic Fracture in a Patient Continuously Having Zoledronic Acid

Saran TANTAVISUT; Aree TANAVALEE; Voranuch THANAKIT; Srihatach NGARMUKOS; Vajara WILAIRATANA; Yongsak WANGROONGSUB

Saran TANTAVISUT; Aree TANAVALEE; Voranuch THANAKIT; Srihatach NGARMUKOS; Vajara WILAIRATANA; Yongsak WANGROONGSUB.

Clinics in Orthopedic Surgery ; : 358-360, 2014.

Article in En | WPRIM | ID: wpr-106807

Responsible library: WPRO

ABSTRACT

ABSTRACT

Zoledronic acid has been used for prevention of osteolytic and osteoblastic bone metastasis. This case report illustrates an undesirable consequence from prolonged usage of zoledronic acid in bone metastasis prevention. Periprosthetic acetabular fracture in a patient treated with zoledronic acid for 7 years was reported. The clinical presentation, radiographic and pathological results were described. This is a rare complication after total hip arthroplasty which should not be ignored especially in patients who received long term bisphosphonate.

Subject(s)

Aged; Female; Humans; Acetabulum/injuries; Arthroplasty, Replacement, Hip/adverse effects; Bone Density Conservation Agents/adverse effects; Bone Neoplasms/prevention & control; Bone Remodeling/drug effects; Breast Neoplasms/pathology; Diphosphonates/adverse effects; Fractures, Spontaneous/chemically induced; Hip Prosthesis; Imidazoles/adverse effects; Osteoarthritis, Hip/surgery; Periprosthetic Fractures/chemically induced; Prosthesis Failure; Reoperation

Key words

Hip arthroplasty; Fracture; Loosening; Zoledronic acid; Bisphosphonate

Fulltext

Add to My VHL

XML

Search on Google

Full text: 1 Index: WPRIM Main subject: Reoperation / Bone Neoplasms / Prosthesis Failure / Breast Neoplasms / Osteoarthritis, Hip / Bone Remodeling / Arthroplasty, Replacement, Hip / Diphosphonates / Bone Density Conservation Agents / Periprosthetic Fractures Limits: Aged / Female / Humans Language: En Journal: Clinics in Orthopedic Surgery Year: 2014 Type: Article

Fulltext

Add to My VHL

XML

Search on Google